Public Company News

Infosys InStep Ranked as the 'Best Internship Program' for Four Consecutive Years

BENGALURU, India, Dec. 1, 2021 /PRNewswire/ -- Infosys  (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that its flagship global internship program, InStep, was ranked as the 'Best Overall Internshi...

2021-12-01 16:58 3541

VIRALEZE™ antiviral nasal spray registered in Vietnam with launch to follow this week

MELBOURNE, Australia, Dec. 1, 2021 /PRNewswire/ -- Australian biotech company Starpharma  today announced that its broad spectrum antiviral nasal spray, VIRALEZE™, has been registered for sale inVietnam, with the product scheduled to launch inVietnam this week. VIRALEZE™...

2021-12-01 16:40 2906

Security Matters Applauded by Frost & Sullivan for Enabling Digitalization of Waste Management & Recycling with Its Cutting-edge Trace and Track Technology Solutions

Next-generation track and trace technology solutions ensure physical and digital tracking of closed-loop recycling, authenticate sustainability claims, and advance plastic waste sorting SAN ANTONIO, Dec. 1, 2021 /PRNewswire/ -- Based on its recent analysis of the industry, Frost & Sullivan recog...

2021-12-01 13:06 2589

GenScript and BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan

TOKYO and SINGAPORE, Dec. 1, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company, and BioComo Incorporation, a drug discovery venture based in Mie prefecture,Japan, today announces a strategic agreement for joint research a...

2021-12-01 12:03 6146

RightCrowd Names Chief Technology Officer as Company Continues to Strengthen Management Team

SEATTLE, Nov. 30, 2021 /PRNewswire/ -- RightCrowd (ASX: RCW / OTCQB: RCWDF), a leading provider of safety, security and compliance solutions, announced that Bryan Jones has joined the company as Chief Technology Officer, a new position based inEurope. Jones joins RightCrowd following 17 years with...

2021-12-01 11:44 2875

Inventec unveils Steelix - a high density storage 2U server system optimized for AMD EPYC (TM) 7003 Series Processors

TAIPEI, Dec. 1, 2021 /PRNewswire/ -- Server manufacturer Inventec (TPE: 2356) has introduced its latest high density storage server Steelix. This new industry-leading server provides efficient computing performance with a single socket solution that supports the new 3rd GenAMD EPYC™ processor. ...

2021-12-01 11:11 2479

Tongcheng-Elong Establishes ESG and Data Security Committee to Promote Sustainable Development

BEIJING, Dec. 1, 2021 /PRNewswire/ -- Tongcheng-Elong Holdings Limited (" Tongcheng-Elong") has formally announced the establishment of an ESG and Data Security Committee to further upgrade its corporate governance as well as policies in environment and society, thus better protecting user privacy...

2021-12-01 10:13 5019

Ascentage Pharma and Innovent Biologics Announce Approval for China's First Third-Generation BCR-ABL TKI Olverembatinib, Marking a Clinical Breakthrough in the Treatment of Chronic Myeloid Leukemia

SUZHOU, China and ROCKVILLE, Md., Nov. 30, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-...

2021-12-01 08:00 1934

Innovent Biologics and Ascentage Pharma Announce the China NMPA Approval for China's First Third-Generation BCR-ABL Inhibitor Olverembatinib for the Treatment of Chronic Myeloid Leukemia

SUZHOU, China, SAN FRANCISCO and ROCKVILLE, Md., Dec. 1, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and...

2021-12-01 08:00 4043

Everest Medicines and Providence Therapeutics Jointly Announce Vaccine Development Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant

SHANGHAI and CALGARY, Canada, Dec. 1, 2021 /PRNewswire/ -- Everest Medicines and Providence Therapeutics ("Providence") jointly announced today that the companies have started working on a new version of COVID-19 vaccine specifically targeting the new Omicron variant. Scientists from the two com...

2021-12-01 08:00 3653

IBM Acquires Hybrid Cloud Consulting Business in Australia

SXiQ's skilled delivery professionals bring deep experience on multicloud platforms ARMONK, N.Y., Dec. 1, 2021 /PRNewswire/ -- IBM (NYSE: IBM) today announced the acquisition of SXiQ, an Australian digital transformation services company specializing in cloud applications, cloud platforms and cl...

2021-12-01 07:00 3422

Secureworks Named a Leader in the IDC MarketScape: Worldwide Incident Readiness Services 2021 Assessment

Report highlights Secureworks' ability to help customers mitigate risks, enhance security postures and strengthen cyber resilience with a portfolio of Incident Readiness services ATLANTA, Dec. 1, 2021 /PRNewswire/ -- Secureworks® (NASDAQ: SCWX), a global leader in cyber security, has been recogn...

2021-12-01 05:45 2074

Hyundai scoops highest accolades at Top Gear Awards

OFFENBACH, Germany, Dec. 1, 2021 /PRNewswire/ -- Hyundai Motor has taken highest honours at theTop Gear annual awards 2021, winning Car of the Year with i20 N and being named overall Manufacturer of the Year in recognition of the brand's class leading model line-up.

2021-12-01 04:00 2557

Hyundai scoops highest accolades at Top Gear Awards

OFFENBACH, Germany, Nov. 30, 2021 /PRNewswire/ -- Hyundai Motor has taken highest honours at theTop Gear annual awards 2021, winning Car of the Year with i20 N and being named overall Manufacturer of the Year in recognition of the brand's class leading model line-up.

2021-12-01 04:00 2183

GA technologies steps its foot into the Southeast Asian market by the acquisition of Dear Life's business in Thailand

TOKYO, Nov. 30, 2021 /PRNewswire/ -- GA technologies Co., Ltd. (Headquarters: Minato District,Tokyo /CEO: Ryo Higuchi / Securities code: 3491/ Hereinafter referred to as "the Company")  announced an M&A decision onNov. 18th, 2021.  Along with this decision, a share exchange was agreed upon betwee...

2021-12-01 01:00 3117

Macronix Becomes Industry's First to Bring 120MHz 1.2V Serial NOR Flash Memories to Mass Production

HSINCHU, Nov. 30, 2021 /PRNewswire/ -- Macronix International Co., Ltd. (TSE: 2337), a leading integrated device manufacturer in the non-volatile memory (NVM) market, today announced it has become the industry's first Serial NOR Flash memory manufacturer to bring 1.2V devices to mass production. ...

2021-12-01 01:00 2906

AS-IP Tech, Inc. Makes Aviation History

NEW YORK, Nov. 30, 2021 /PRNewswire/ -- AS-IP Tech, Inc. (USOTC: IPTK) World First Bluetooth Passenger Network, fflya is the first major change in aircraft passenger connectivity in over two decades. Free Messaging fflya Text&Fly By Wizz App a...

2021-11-30 23:00 3605

EonStor DS U.2 SSD Boosts Performance for Database and Virtualization Applications

TAIPEI, Nov. 30, 2021 /PRNewswire/ -- Infortrend® Technology, Inc.  (TWSE: 2495), the industry-leading enterprise storage provider, introduces U.2 NVMe SSD EonStor DS 4000U ...

2021-11-30 23:00 2931

Arria NLG Acquires Boost Sport AI to Enhance Industry Portfolio and Re-Define the Personalized, Data-Driven Sport Experience

Partnership between NLG innovator and proprietary data analytics company fuels acquisition; combines the power and integration of data, video, player tracking, and NLG to serve the sports industry from performance to media, sports books, and e-commerce. MORRISTOWN, N.J. and SEATTLE, Nov. 30, 202...

2021-11-30 22:53 2635

RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results

RedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against Omicron Acting independently of spike protein mutation, opaganib and RHB-107's unique host-targeted mechanisms of action hold potential versus Omicron and other variants -- Phase 2/3 study s...

2021-11-30 22:30 4812